DOI: 10.36347/sjams.2017.v05i02.066

Pages: 635-637

Postoperative pain relief in pediatric surgery patients has remained an issue of ongoing debate. This study was undertaken to describe our own experience with postoperative pain relief in pediatric surgery patients using bupivacaine 0.25% and ropivacaine 0.5% as postoperative incisional skin infiltration. This was a prospective randomized double blind study of patients of age group 4-12 years in which postoperative pain relief is achieved using incisional wound infiltration with bupivacaine 0.25% and ropivacaine 0.5% . A total of 120 patients of ASA G-1, 2 of age group 4-12 years were studied. They underwent elective operation (herniotomy).they were divided in three groups A, B and C, each having 40 patients. Before skin closure infiltration done on each side of incision with ropivacaine .5% in group A, group B received bupivacaine .25% and group C did not received any infiltration. In all 3 groups further postoperative analgesia was administered in postoperative ICU. Pain score evaluated at every 1 hour. Analgesic request by the patient was more than 4 on VAS. In ropivacaine and bupivacaine group pain was less even at 10 hrs in compare to group C (not received any local infiltration). Analgesic request was also less in ropivacaine group i.e. group A. Bradycardia and some ECG changes are associated with bupivacaine but not with ropivacaine. Thus our prospective, randomized double blind study demonstrated excellent postoperative analgesia using wound infiltration with ropivacaine without severe side effects in pediatric patients.